The Food and Drug Administration has upgraded a December recall of Classic Lays Potato Chips to Class 1, the highest priority designated by the agency.
Federal regulators have warned a Waco, Texas, company that its human amniotic products are “unlicensed” and “unapproved,” and that its manufacturing process violates safety regulations. The U.S. Food & Drug Administration sent a warning letter to Frontier Biologics in November,
It's a new year, which means several new food items were deemed unsafe due to recalls by the U.S. Food and Drug Administration.
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers an easier way to identify nutrients linked to chronic diseases.
Idaho, Kansas and Missouri can pursue legal action to prohibit the Food and Drug Administration from allowing online prescriptions.
A federal judge in Texas ruled that three states can challenge the current rules of accessibility for abortion pills.
MONDAY, Jan. 27, 2025 (HealthDay News) -- Reports of cats becoming seriously ill or dying after consuming raw pet food or milk tainted with the deadly bird flu virus have prompted the U.S. Food and Drug Administration (FDA) to urge pet food manufacturers to take extra precautions.
A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide.
Emboldened by Robert F. Kennedy Jr’s nomination and disdain for pandemic-era mandates, skeptics are pushing for bills to make it easier to opt out of vaccines.
Enjoying momentum thanks to Robert F. Kennedy Jr.’s nomination as federal health secretary, vaccine skeptics are pushing state-level bills to block mandates and give parents and workers greater latitude to opt out.
A judge in Texas ruled Thursday that three other ... The states want the federal Food and Drug Administration to prohibit telehealth prescriptions for mifepristone and require that it be used ...
A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?